Vanessa M. Knab - Concepedia

Author

Vanessa M. Knab

University of Veterinary Medicine Vienna ORCID

Also Known As

V. M. Knab, Vanessa M. Knab, Vanessa Maria Knab

Publications

290

Citations

H-Index

Concepts

All Affiliations

University of Veterinary Medicine Vienna Medical University of Vienna Austrian Academy of Sciences CeMM Research Center for Molecular Medicine St Anna Children's Hospital

About

Vanessa M. Knab is an author at University of Veterinary Medicine Vienna specializing in cell biology, medicine, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	53
2	Cell Biology	2	2	53
3	Health Sciences	1	1	41
4	Endocrinology	1	1	41
5	Immunology	1	1	41

Vanessa M. Knab

Publications

287

Citations

H-Index

Page 1

	Year	Citations
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia Ingeborg Menzl, Tinghu Zhang, Angelika Berger‐Becvar, Nature Communications	2019	71
A STAT5B–CD9 axis determines self-renewal in hematopoietic and leukemic stem cells Sebastian Kollmann, Reinhard Grausenburger, Thorsten Klampfl, Blood	2021	44
Opioids drive breast cancer metastasis through the δ-opioid receptor and oncogenic STAT3 Sabrina Tripolt, Heidi A. Neubauer, Vanessa M. Knab, Neoplasia	2021	43
Acute Parathyroid Hormone Injection Increases C-Terminal but Not Intact Fibroblast Growth Factor 23 Levels Vanessa M. Knab, Braden Corbin, Olena Andrukhova, Endocrinology Human GrowthImmunologyParathyroid DiseasePathologyParathyroid Gland	2017	41
Activation of HIF-1α by δ-Opioid Receptors Induces COX-2 Expression in Breast Cancer Cells and Leads to Paracrine Activation of Vascular Endothelial Cells Alexandra Schoos, Cordula Gabriel, Vanessa M. Knab, Journal of Pharmacology and Experimental Therapeutics	2019	24
Triple-negative breast cancer cells rely on kinase-independent functions of CDK8 to evade NK-cell-mediated tumor surveillance Vanessa M. Knab, Dagmar Gotthardt, Klara R. Klein, Cell Death and Disease	2021	18
In vitro study to assess the efficacy of CDK4/6 inhibitor Palbociclib (PD‐0332991) for treating canine mammary tumours Alexandra Schoos, Vanessa M. Knab, Cordula Gabriel, Veterinary and Comparative Oncology Chemoprevention StrategyTumor BiologyAnti-cancer AgentCf41 CellsRadiation Oncology	2019	12
T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo Klara R. Klein, Agnieszka Witalisz‐Siepracka, Dagmar Gotthardt, Frontiers in Immunology	2021	12
Loss of NKG2D in murine NK cells leads to increased perforin production upon long‐term stimulation with IL‐2 Daniela Prinz, Klara R. Klein, Julia List, European Journal of Immunology	2020	11
CDK6 Degradation Is Counteracted by p16INK4A and p18INK4C in AML Belinda S. Schmalzbauer, Teresemary Thondanpallil, Gerwin Heller, Cancers	2022	11

Page 1